Ergomed Clinical Research Ltd.

	Address:	Dubai International Academic City, P.O. Box 501708, Dubai, UAE
		P.O. Box 501708, Dubai, UAE.
	Tel:	+ 971 4 374 9787
	Fax:	+ 971 4 424 3948
	Email:	This e-mail address is being protected from spambots. You need JavaScript enabled to view it
	Website:	www.ergomed-cro.com

ERGOMED is a dynamic and successful transatlantic clinical development and research company, with operations in over 20 European countries and North America. ERGOMED is headquartered in Frankfurt, Germany, with additional operational offices in Zagreb, Croatia; Krakow, Poland; Guildford, England; Novi Sad, Serbia; Moscow, Russia; Madrid, Spain; and San Antonio, Texas US. In addition an office in Dubai was opened in October 2007 to support services in Middle East and India.

While ERGOMED specializes in the fields of Oncology and Neurology, with added strengths in Endocrinology and Immunology, we are experienced with a variety of indications. The company has planned, managed, monitored, and reported clinical trials with a range of technologies that include small molecule drugs, monoclonal antibodies and other targeted agents, cancer vaccines and immunotherapy, radioactive agents, and photodynamic therapies. ERGOMED has experience in all stages of clinical trials. Besides a number of ongoing phase III and IV studies, ERGOMED is currently managing 4 FDA pivotal studies across 15 countries. Other pivotal studies have already been approved by the EMEA and FDA.

ERGOMED’s success is primarily due to its highly trained, experienced, and dedicated workforce. ERGOMED has around 90 employees, of which more than 25% are medical doctors and life-sciences PhDs. Out of the 25 MDs, 10 are specialists. The expertise of these individuals as well as our highly qualified consultants covers all aspects of drug and device development and marketing, including:

Preclinical Development
Pharmacokinetics
Clinical Pharmacology
Drug Safety and Pharmacovigilance
Biostatistics and data management (including electronic data capture)
Global regulatory affairs
CMC, including biologics
International clinical operations
Quality assurance

Ergomed offers a global solution to pharmaceutical and Biotech companies that are planning on expanding into new markets while keeping a very strong focus on the uniqueness, that is regulatory and clinical, of each individual market.